Newsfeed

Every published oncology item from an approved source, most recent first. No account required — this is the unfiltered stream, not personalized to any follows.

Items are tagged with the biomarkers and tumour types they resolve to; each tag opens that record, and every record’s page carries the same items back.

This demo serves a captured snapshot of the feed, not a live connection to the sources.

PubMed Central · Aug 19, 2026
Mutation-Immune Crosstalk Contextualizes CAF-Associated ARPC1A Programs and Cisplatin Response in Gastric Cancer.
- gastric cancer (tumour type)
Read at PubMed Central
PubMed Central · Aug 19, 2026
VEZT promotes pancreatic cancer progression by stabilizing SLC25A24 and preserving mitochondrial function.
- pancreatic cancer (tumour type)
Read at PubMed Central
PubMed Central · Aug 19, 2026
Complete tumour regression of in-transit melanoma following discontinuation of talimogene laherparepvec.
- melanoma (tumour type)
Read at PubMed Central
PubMed Central · Aug 19, 2026
CDK4/6 inhibitors as conditional immune-priming agents in breast cancer: therapeutic windows, sequencing strategies, and rational combinations with immunotherapy, radiotherapy, and antibody-drug conjugates.
- breast cancer (tumour type)
Read at PubMed Central
PubMed Central · Aug 19, 2026
Host-Microbe Mechanisms of Fusobacterium nucleatum in Colorectal Cancer.
- colorectal cancer (tumour type)
Read at PubMed Central
American Cancer Society · Aug 18, 2026
County-Level Medical Debt Linked to Advanced-Stage Cancers and Worse Survival Among Newly Diagnosed U.S. Adults
Read at American Cancer Society
PubMed Central · Aug 18, 2026
Standard Therapy Plus Adjunctive Vegan Lifestyle Intervention in Metastatic Prostate Cancer: A Case Report.
- prostate cancer (tumour type)
Read at PubMed Central
PubMed Central · Aug 18, 2026
Associations between legacy and emerging per and polyfluoroalkyl substances (PFAS) bioaccumulation and clinicopathological characteristics in breast cancer.
- breast cancer (tumour type)
Read at PubMed Central
PubMed Central · Aug 18, 2026
Evaluation of the safety and efficacy of (225)Ac-PSMA-CY313 in metastatic castration-resistant prostate cancer: preliminary results.
- prostate cancer (tumour type)
Read at PubMed Central
PubMed Central · Aug 18, 2026
A multicohort, biomarker-driven phase 2 trial of personalized total neoadjuvant therapy with targeted agents for high-risk rectal cancer (The TRAINER study).
- colorectal cancer (tumour type)
Read at PubMed Central
PubMed Central · Aug 18, 2026
Impact of COVID-19 Vaccination on Patients with Non-Small Cell Lung Cancer Receiving First-Line Immune Checkpoint Inhibitor Therapy: Real-World Evidence from Romania.
- non-small cell lung cancer (tumour type)
Read at PubMed Central
PubMed Central · Aug 18, 2026
Liver microenvironment-driven immunosuppressive niche in colorectal cancer liver metastasis and its therapeutic remodeling.
- colorectal cancer (tumour type)
Read at PubMed Central
PubMed Central · Aug 18, 2026
Adiposity and risk of breast cancer in 280 000 Chinese women: a prospective cohort study.
- breast cancer (tumour type)
Read at PubMed Central
PubMed Central · Aug 18, 2026
[CRISPR-Cas9 activation screening identifies candidate chemokine regulators of ter-tiary lymphoid structure formation in bladder cancer].
- urothelial carcinoma (tumour type)
Read at PubMed Central
PubMed Central · Aug 18, 2026
Synthetically engineered probiotic suppresses colorectal cancer via inhibition of Wnt/β-catenin signaling.
- colorectal cancer (tumour type)
Read at PubMed Central
PubMed Central · Aug 18, 2026
[Impact of coexistent low-grade components on the prognosis of high-grade non-muscle invasive bladder cancer].
- urothelial carcinoma (tumour type)
Read at PubMed Central
PubMed Central · Aug 18, 2026
Total moderate-to-vigorous physical activity across the adult life course and the risk of invasive ovarian cancer.
- ovarian cancer (tumour type)
Read at PubMed Central
PubMed Central · Aug 18, 2026
Trastuzumab Deruxtecan in HER2-Positive Metastatic Breast Cancer: Real-World Outcomes and Treatment Transition Patterns in a Chinese Cohort.
- ERBB2 (biomarker)
- breast cancer (tumour type)
Read at PubMed Central
PubMed Central · Aug 18, 2026
Effect of Digital Health Interventions on the Nutritional Status and Quality of Life of Patients With Colorectal Cancer: Systematic Review and Meta-Analysis of Randomized Controlled Trials.
- colorectal cancer (tumour type)
Read at PubMed Central
PubMed Central · Aug 18, 2026
[Feasibility and clinical value of a prostate cancer screening model based on biparametric magnetic resonance imaging combined with prostate-specific antigen in a Chinese population].
- prostate cancer (tumour type)
Read at PubMed Central

Newsfeed

Mutation-Immune Crosstalk Contextualizes CAF-Associated ARPC1A Programs and Cisplatin Response in Gastric Cancer.

VEZT promotes pancreatic cancer progression by stabilizing SLC25A24 and preserving mitochondrial function.

Complete tumour regression of in-transit melanoma following discontinuation of talimogene laherparepvec.

CDK4/6 inhibitors as conditional immune-priming agents in breast cancer: therapeutic windows, sequencing strategies, and rational combinations with immunotherapy, radiotherapy, and antibody-drug conjugates.

Host-Microbe Mechanisms of Fusobacterium nucleatum in Colorectal Cancer.

County-Level Medical Debt Linked to Advanced-Stage Cancers and Worse Survival Among Newly Diagnosed U.S. Adults

Standard Therapy Plus Adjunctive Vegan Lifestyle Intervention in Metastatic Prostate Cancer: A Case Report.

Associations between legacy and emerging per and polyfluoroalkyl substances (PFAS) bioaccumulation and clinicopathological characteristics in breast cancer.

Evaluation of the safety and efficacy of (225)Ac-PSMA-CY313 in metastatic castration-resistant prostate cancer: preliminary results.

A multicohort, biomarker-driven phase 2 trial of personalized total neoadjuvant therapy with targeted agents for high-risk rectal cancer (The TRAINER study).

Impact of COVID-19 Vaccination on Patients with Non-Small Cell Lung Cancer Receiving First-Line Immune Checkpoint Inhibitor Therapy: Real-World Evidence from Romania.

Liver microenvironment-driven immunosuppressive niche in colorectal cancer liver metastasis and its therapeutic remodeling.

Adiposity and risk of breast cancer in 280 000 Chinese women: a prospective cohort study.

[CRISPR-Cas9 activation screening identifies candidate chemokine regulators of ter-tiary lymphoid structure formation in bladder cancer].

Synthetically engineered probiotic suppresses colorectal cancer via inhibition of Wnt/β-catenin signaling.

[Impact of coexistent low-grade components on the prognosis of high-grade non-muscle invasive bladder cancer].

Total moderate-to-vigorous physical activity across the adult life course and the risk of invasive ovarian cancer.

Trastuzumab Deruxtecan in HER2-Positive Metastatic Breast Cancer: Real-World Outcomes and Treatment Transition Patterns in a Chinese Cohort.

Effect of Digital Health Interventions on the Nutritional Status and Quality of Life of Patients With Colorectal Cancer: Systematic Review and Meta-Analysis of Randomized Controlled Trials.

[Feasibility and clinical value of a prostate cancer screening model based on biparametric magnetic resonance imaging combined with prostate-specific antigen in a Chinese population].